If you missed the webinar from Pathology Webinars on “How to Reduce Your Risk of HIPAA Rule Violations and Avoid Thousands in Fines and Penalties or Other Damaging Action by the OCR,” you still have a chance to purchase the CD of this event.
The Office of Civil Rights (OCR) is taking an increasingly active role in its enforcement of HIPAA rules and regulations as well as investigations into suspected violations. And it’s no longer just major laboratories—OCR is now reviewing all providers.
In addition, OCR continues to audit laboratories and pathology practices under its Phase 2 HIPAA Audit Program. While these audits help OCR identify best practices, they also ensure that your laboratory or practice is compliant with specific standards of the Privacy, Security, and Breach Notification Rules. Noncompliance found during an audit can lead to an OCR investigation, which could result in fines, penalties, and other corrective action. And with the dramatic increase in fines and penalties recently, they could put your laboratory’s very survival in jeopardy.
To reduce your risk of serious action by OCR, take steps now to assess your HIPAA compliance program and fix any policies or procedures that could cause a finding of noncompliance.
Purchase the CD of this session that originally aired on February 9, 2017 and you’ll find out what your lab or pathology practice’s compliance obligations are under HIPAA, and what you need to do to meet them. Experts Emily Johnson and Jane Pine Wood show you what you can do to reduce your lab’s risk of a potential breach. You’ll also get details of recent OCR enforcement actions and how to avoid the types of problems that have gotten other labs in trouble with the agency.
Whether you’re a laboratory manager, compliance officer, general counsel, pathology practice manager—anyone whose organization needs to ensure compliance with HIPAA rules to avoid significant fines and penalties—this is one webinar you can’t afford to miss.
Emily Johnson is an associate in the business department at McDonald Hopkins. She focuses primarily on matters for clients in the healthcare industry. Her health law experience includes mergers and acquisitions and general corporate assistance.
Ms. Johnson has worked with laboratories and pathology groups on regulatory, licensing, compliance, reimbursement, contractual, and corporate matters. She has provided support to entities with respect to professional licensure laws, CLIA standards and state laboratory laws, government and private payer reimbursement, and fraud and abuse rules.
Prior to joining McDonald Hopkins, Ms. Johnson served as healthcare attorney/senior consultant at a national legal-based healthcare management consulting firm and was outside counsel to the National Association of Boards of Pharmacy.
Ms. Johnson earned a JD from The John Marshall Law School in 2010 and a BA, Dean’s List, from Illinois Wesleyan University.
Jane Pine Wood has been Chief Legal Counsel, Chief Compliance Officer, at BioReference Laboratories, Inc., an OPKO Health company and the third largest independent clinical laboratory in the country, since late 2016.
Prior to joining BioReference Laboratories, Ms. Wood was a member of McDonald Hopkins, LLC which specializes in health law, including regulatory, compliance, and Medicaid and Medicare reimbursement issues, among others. She represented physicians, hospitals, clinical and anatomic laboratories, clinics, independent practice associations, and integrated delivery systems in corporate, regulatory, reimbursement, contractual, and other areas.
In her almost 30 years representing laboratory and pathology providers, Ms. Wood has focused on regulatory compliance, payer relations and contracting, HIPAA privacy and security, and healthcare contracting.
Ms. Wood received her JD degree in 1987 from Vanderbilt University School of Law and is admitted to practice in Massachusetts, Ohio, and Tennessee.